Reduce Patient Anxiety
Oraqix is a safe alternative to injectable anesthesia
Monica Monsantofils, RDH, PD Dip
West Clinical Educator
Figure 1 | Many patients are fearful and apprehensive of needles and injections in dentistry. Local anesthetics may also take valuable treatment time to be effective. I have found that not all patients require or want local anesthesia for scaling and root planing. With Oraqix (lidocaine and prilocaine periodontal gel) 2.5%/2.5% non-injectable anesthetic gel, I am able to offer many of my patients an effective alternative to achieve profound anesthesia without using needles and invasive injections.
Oraqix is a non-injectable anesthetic delivered through a blunt applicator tip easily inserted into the sulcus or periodontal pocket, achieving anesthesia in just 30 seconds. The brief onset enables me to work efficiently and effectively to accomplish my scaling and root planing goals within a single appointment time. I have found that Oraqix lasts for approximately 20 minutes, providing anesthesia to specific sites or an entire quadrant based on the patient’s needs. I am able to dispense additional applications of Oraqix as required to complete treatment during a single appointment. Patients appreciate the absence of the prolonged effects of anesthesia that are often experienced with injectable anesthetic. Additionally, I find patient acceptance high with Oraqix as patients will not experience any postoperative discomfort at the injection site.
By including Oraqix as an option in my armamentarium, I am able to improve patient outcomes dramatically. Patients are more comfortable both physically and emotionally by reducing pain and anxiety. I find Oraqix to be a very effective, easy, inexpensive, and efficient option for local anesthetic.
Oraqix can be used for single-tooth or full-mouth scaling and root planing. After a fast onset of 30 seconds, it typically provides a 20-minute anesthesia duration. It is safe for inflamed tissues with a maximum dosage of five cartridges and ensures returning patients who experience reduced pain and increased comfort with its needle-free application.
Oraqix is not for injection and is contraindicated in patients who are hypersensitive to local anesthetics. It should not be used in patients with congenital or idiopathic methemoglobinemia. Exercise caution when administering to a nursing woman. Safety and effectiveness in pediatric patients have not been established. Oraqix should not be used in patients with congenital or idiopathic methemoglobinemia.
For over 100 years, Dentsply has ensured quality at each step of a product’s journey from collection of active molecule until it reaches your office. For full prescribing information of Oraqix, please see page 68.